0.4225

1.81% 0.0075

Pre-market: .42 -0.0025 -0.59%

Aethlon Medical Inc (AEMD)

Overview News Price History Financials Discussions Forecast Stock Split

Aethlon Medical Inc stock is traded at $0.4225, with a volume of 185.95K. It is up +1.81% in the last 24 hours and down -33.06% over the past month. Aethlon Medical Inc is a medical therapeutic company. The company is focused on addressing unmet needs in health and biodefense. The company is focused on the development of Hemopurifier, a clinical-stage therapeutic device designed to combat cancer and eliminate life-threatening viruses from the circulatory system.

Previous Close:

$0.415

Open:

$0.409

24h Volume:

185.95K

Relative Volume:

0.06

Market Cap:

$6.11M

Revenue:

$294.20K

Net Income/Loss:

$-12.25M

P/E Ratio:

-0.0837

EPS:

-5.05

Net Cash Flow:

$-10.77M

1W Performance:

-8.19%

1M Performance:

-33.06%

6M Performance:

+10.03%

1Y Performance:

-74.55%

1-Day Range:

$0.395

$0.44

1-Week Range:

$0.395

$0.4725

52-Week Range:

$0.2375

$1.85

Aethlon Medical Inc Stock (AEMD) Company Profile

Name

Aethlon Medical Inc

Sector

Healthcare (1169)

Industry

Medical Devices (159)

Phone

619-941-0360

Address

11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA

Employee

Twitter

@Aethlon_Medical

Next Earnings Date

2024-12-13

Latest SEC Filings

AEMD's Discussions on Twitter

Compare AEMD with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AEMD Aethlon Medical Inc	0.4225	6.11M	294.20K	-12.25M	-10.77M	-5.05
ABT Abbott Laboratories	129.89	225.27B	41.95B	13.40B	6.35B	7.65
BSX Boston Scientific Corp	95.37	140.74B	16.75B	1.85B	2.37B	1.25
SYK Stryker Corp	363.66	138.77B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	92.33	118.39B	33.20B	4.26B	5.47B	3.29
EW Edwards Lifesciences Corp	67.95	39.95B	5.72B	4.17B	259.90M	6.97

Aethlon Medical Inc Stock (AEMD) Latest News

Mar 12, 2025

Aethlon Medical (NASDAQ:AEMD) Earns Sell Rating from Analysts at StockNews.com - Defense World

Mar 12, 2025

Mar 11, 2025

Aethlon Medical’s (AEMD) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

Mar 11, 2025

Mar 10, 2025

Buy Rating for Aethlon Medical Driven by Hemopurifier’s Potential in Organ Transplantation and Projected Growth - TipRanks

Mar 10, 2025

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - Investorideas.com newswire

Mar 10, 2025

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal - StockTitan

Mar 10, 2025

Mar 07, 2025

Aethlon Medical (NASDAQ:AEMD) Receives “Buy” Rating from HC Wainwright - Defense World

Feb 20, 2025

Feb 19, 2025

Aethlon Medical (NASDAQ:AEMD) Raised to Sell at StockNews.com - Defense World

Feb 19, 2025

Feb 17, 2025

Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Down 21.3% in January - Defense World

Feb 17, 2025

Feb 15, 2025

Aethlon Medical strengthens oncology trial with protocol updates and cost reductions - MSN

Feb 15, 2025

Feb 13, 2025

Aethlon Medical IncThe company expects to conduct a capital raise that - Smartkarma

Feb 13, 2025

Aethlon’s Earnings Call: Trials and Cost Strategies - TipRanks

Feb 13, 2025

Aethlon Medical, Inc. (NASDAQ:AEMD) Q3 2025 Earnings Call Transcript - Insider Monkey

Feb 13, 2025

Live Investor Update: Aethlon Medical Unveils Latest Cancer Treatment ProgressCEO Takes Questions - StockTitan

Feb 13, 2025

Aethlon Medical operating expenses drop 50% in Q3 2024 - Medical Buyer

Feb 13, 2025

Earnings call transcript: Aethlon Medical Q4 2024 sees cost cuts, stock rises - Investing.com Nigeria

Feb 13, 2025

Feb 12, 2025

Aethlon Medical Reports Q3 Results and Corporate Update - TipRanks

Feb 12, 2025